Xspray Pharma AB (publ) (LON:0GHZ)

London flag London · Delayed Price · Currency is GBP · Price in SEK
24.70
-0.30 (-1.20%)
At close: Feb 10, 2026
Market Cap86.44M -2.9%
Revenue (ttm)n/a
Net Income-17.09M
EPS-0.47
Shares Outn/a
PE Ration/a
Forward PE3.84
Dividendn/a
Ex-Dividend Daten/a
Volume47
Average Volume3,434
Open24.70
Previous Close25.00
Day's Range24.70 - 24.70
52-Week Range24.70 - 61.40
Beta0.82
RSI40.84
Earnings DateFeb 12, 2026

About Xspray Pharma AB

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the treatment of chronic myeloid leukemia (CML)and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib for the treatment of CML; XS008, an axitinib for the treatment of kidney cancer; and XS025, a amorphous non-crystalline cabozantinib for the treatment of renal cell carcinoma and other cancers. It has partn... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2003
Employees 26
Stock Exchange London Stock Exchange
Ticker Symbol 0GHZ
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements